Exact Mass: 722.2058048
Exact Mass Matches: 722.2058048
Found 70 metabolites which its exact mass value is equals to given mass value 722.2058048,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Citbismine D
12-[5,9-dihydroxy-2-(2-hydroxypropan-2-yl)-10-methoxy-11-methyl-6-oxo-1H,2H,6H,11H-furo[2,3-c]acridin-1-yl]-7,11-dihydroxy-6-methoxy-2,2,5-trimethyl-5,10-dihydro-2H-1-oxa-5-azatetraphen-10-one
C40H38N2O11 (722.2475478000001)
Citbismine D is found in citrus. Citbismine D is an alkaloid from roots of Marsh grapefruit (Citrus paradisi). Alkaloid from roots of Marsh grapefruit (Citrus paradisi). Citbismine D is found in citrus.
6)-galactoside
3,5,7,3,4-Pentahydroxyflavone 3- (2",3",4"-triacetyl-alpha-L-arabinopyranosyl) (1->6) -galactoside
Formononetin 7-O-(2,6-di-O-(E-p-coumaroyl)glucoside)
7-Hydroxy-4-methoxyisoflavone 7-O-(2,6-di-O-E-p-coumaroyl)-glucoside
Quercetin 3- (2',3',5'-triacetyl-alpha-L-arabinofuranosyl) (1->6) -glucoside
3,5,7,3,4-Pentahydroxyflavone 3- (2",3",5"-triacetyl-alpha-L-arabinofuranosyl) (1->6) -glucoside
[(2S,3S,4R,5R,6S)-6-[[(1aS,1bS,2S,5aR,6S,6aS)-1a-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,5a,6,6a-tetrahydro-1bH-oxireno[5,6]cyclopenta[1,3-c]pyran-6-yl]oxy]-4,5-diacetyloxy-2-methyloxan-3-yl] (E)-3-phenylprop-2-enoate
[(2S,3S,4R,5R,6S)-6-[[(1aS,1bS,2S,5aR,6S,6aS)-1a-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,5a,6,6a-tetrahydro-1bH-oxireno[5,6]cyclopenta[1,3-c]pyran-6-yl]oxy]-4,5-diacetyloxy-2-methyloxan-3-yl] (E)-3-phenylprop-2-enoate
[(2S,3R,4R,5S,6S)-2-[[(1aS,1bS,2S,5aR,6S,6aS)-1a-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,5a,6,6a-tetrahydro-1bH-oxireno[5,6]cyclopenta[1,3-c]pyran-6-yl]oxy]-4,5-diacetyloxy-6-methyloxan-3-yl] (E)-3-phenylprop-2-enoate
[(2S,3R,4R,5S,6S)-2-[[(1aS,1bS,2S,5aR,6S,6aS)-1a-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,5a,6,6a-tetrahydro-1bH-oxireno[5,6]cyclopenta[1,3-c]pyran-6-yl]oxy]-4,5-diacetyloxy-6-methyloxan-3-yl] (E)-3-phenylprop-2-enoate
5-O-beta-D-Glucosylluteoliflavan-(4->8)-eriodictyol
5-O-beta-D-Glucosylluteoliflavan-(4->8)-eriodictyol
Quercetin 3-(2,3,5-triacetyl-alpha-L-arabinofuranosyl)(1->6)-glucoside
Quercetin 3-(2,3,5-triacetyl-alpha-L-arabinofuranosyl)(1->6)-glucoside
(2S)-5,7,5-trihydroxyflavanone 2-O-beta-D-2,6-O-diacetylglucopyranosyl-(1->3)-alpha-L-2-O-acetylrhamnopyranoside
(2S)-5,7,5-trihydroxyflavanone 2-O-beta-D-2,6-O-diacetylglucopyranosyl-(1->3)-alpha-L-2-O-acetylrhamnopyranoside
dimethyl 2,2-sulfanediylbis{3-hydroxy-6-[(2-hydroxy-6-methoxy-4-methylphenyl)carbonyl]-5-methoxybenzoate}|guignasulfide
dimethyl 2,2-sulfanediylbis{3-hydroxy-6-[(2-hydroxy-6-methoxy-4-methylphenyl)carbonyl]-5-methoxybenzoate}|guignasulfide
24-alpha-D-glucuronopyranosyl-1,4-beta-D-xylotetraose
24-alpha-D-glucuronopyranosyl-1,4-beta-D-xylotetraose
O-beta-D-xylopyranosyl-(1<*>4)-O-<5-O-(trans-feruloyl)-alpha-L-arabinofuranosyl>-(1<*>3)-O-beta-D-xylopyranosyl-(1<*>4)-D-xylopyranose
O-beta-D-xylopyranosyl-(1<*>4)-O-<5-O-(trans-feruloyl)-alpha-L-arabinofuranosyl>-(1<*>3)-O-beta-D-xylopyranosyl-(1<*>4)-D-xylopyranose
aeruginosin DA722|D-o,o-di-Cl-Hpla-D-Leu-L-Choi-6-sulfate-agmatine
aeruginosin DA722|D-o,o-di-Cl-Hpla-D-Leu-L-Choi-6-sulfate-agmatine
(2S)-5,7,5-trihydroxyflavanone 2-O-beta-D-3,6-O-diacetylglucopyranosyl-(1->3)-alpha-L-2-O-acetylrhamnopyranoside
(2S)-5,7,5-trihydroxyflavanone 2-O-beta-D-3,6-O-diacetylglucopyranosyl-(1->3)-alpha-L-2-O-acetylrhamnopyranoside
(2S)-5,7,5-trihydroxyflavanone 2-O-beta-D-4,6-O-diacetylglucopyranosyl-(1->3)-alpha-L-2-O-acetylrhamnopyranoside
(2S)-5,7,5-trihydroxyflavanone 2-O-beta-D-4,6-O-diacetylglucopyranosyl-(1->3)-alpha-L-2-O-acetylrhamnopyranoside
jaspamide G
jaspamide G
C36H43BrN4O7 (722.2314948000001)
A cyclodepsipeptide isolated from Jaspis splendens. A derivative of jaspamide, it exhibits anti-tumour activity.
Quercetin 3-(2,3,4-triacetyl-alpha-L-arabinopyranosyl)(1->6)-glucoside
Quercetin 3-(2,3,4-triacetyl-alpha-L-arabinopyranosyl)(1->6)-glucoside
Pelargonidin 3-(6-malonylglucoside)-5-(6-acetylglucoside)
Pelargonidin 3-(6-malonylglucoside)-5-(6-acetylglucoside)
C34H42O17_(1aS,1bS,2S,5aR,6S,6aS)-6-({2,3-Di-O-acetyl-6-deoxy-4-O-[(2E)-3-phenyl-2-propenoyl]-alpha-L-mannopyranosyl}oxy)-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-2-yl beta-D-glucopyranoside
NCGC00169152-03_C34H42O17_(1aS,1bS,2S,5aR,6S,6aS)-6-({2,3-Di-O-acetyl-6-deoxy-4-O-[(2E)-3-phenyl-2-propenoyl]-alpha-L-mannopyranosyl}oxy)-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-2-yl beta-D-glucopyranoside
C34H42O17_(1aS,1bS,2S,5aR,6S,6aS)-6-({2,4-Di-O-acetyl-6-deoxy-3-O-[(2E)-3-phenyl-2-propenoyl]-alpha-L-mannopyranosyl}oxy)-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-2-yl beta-D-glucopyranoside
NCGC00179976-03_C34H42O17_(1aS,1bS,2S,5aR,6S,6aS)-6-({2,4-Di-O-acetyl-6-deoxy-3-O-[(2E)-3-phenyl-2-propenoyl]-alpha-L-mannopyranosyl}oxy)-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-2-yl beta-D-glucopyranoside
C34H42O17_(1aS,1bS,2S,5aR,6S,6aS)-6-({3,4-Di-O-acetyl-6-deoxy-2-O-[(2E)-3-phenyl-2-propenoyl]-alpha-L-mannopyranosyl}oxy)-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-2-yl beta-D-glucopyranoside
NCGC00169427-03_C34H42O17_(1aS,1bS,2S,5aR,6S,6aS)-6-({3,4-Di-O-acetyl-6-deoxy-2-O-[(2E)-3-phenyl-2-propenoyl]-alpha-L-mannopyranosyl}oxy)-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-2-yl beta-D-glucopyranoside
[(2S,3S,4R,5R,6S)-6-[[(1aS,1bS,2S,5aR,6S,6aS)-1a-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,5a,6,6a-tetrahydro-1bH-oxireno[5,6]cyclopenta[1,3-c]pyran-6-yl]oxy]-4,5-diacetyloxy-2-methyloxan-3-yl] (E)-3-phenylprop-2-enoate_6.1\\%
[(2S,3S,4R,5R,6S)-6-[[(1aS,1bS,2S,5aR,6S,6aS)-1a-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,5a,6,6a-tetrahydro-1bH-oxireno[5,6]cyclopenta[1,3-c]pyran-6-yl]oxy]-4,5-diacetyloxy-2-methyloxan-3-yl] (E)-3-phenylprop-2-enoate_6.1\\%
[(2S,3S,4R,5R,6S)-6-[[(1aS,1bS,2S,5aR,6S,6aS)-1a-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,5a,6,6a-tetrahydro-1bH-oxireno[5,6]cyclopenta[1,3-c]pyran-6-yl]oxy]-4,5-diacetyloxy-2-methyloxan-3-yl] (E)-3-phenylprop-2-enoate_major
[(2S,3S,4R,5R,6S)-6-[[(1aS,1bS,2S,5aR,6S,6aS)-1a-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,5a,6,6a-tetrahydro-1bH-oxireno[5,6]cyclopenta[1,3-c]pyran-6-yl]oxy]-4,5-diacetyloxy-2-methyloxan-3-yl] (E)-3-phenylprop-2-enoate_major
Quercetin 3-(2,3,4-triacetyl-alpha-L-arabinopyranosyl)(1->6)-galactoside
Quercetin 3-(2,3,4-triacetyl-alpha-L-arabinopyranosyl)(1->6)-galactoside
Citbismine D
12-[5,9-dihydroxy-2-(2-hydroxypropan-2-yl)-10-methoxy-11-methyl-6-oxo-1H,2H,6H,11H-furo[2,3-c]acridin-1-yl]-7,11-dihydroxy-6-methoxy-2,2,5-trimethyl-5,10-dihydro-2H-1-oxa-5-azatetraphen-10-one
C40H38N2O11 (722.2475478000001)
(-)-(3R,4R)-3-(PROPYLAMINO)-6-METHOXY-1-BENZOPYRAN-4-OLMANDELATESALT
(-)-(3R,4R)-3-(PROPYLAMINO)-6-METHOXY-1-BENZOPYRAN-4-OLMANDELATESALT
5-phenyl-2-[2-[[5-phenyl-3-(3-sulfopropyl)-2(3h)-benzoxazolylidene]methyl-1-butenyl]-3-(3-sulfopropyl)benzoxazolium hydroxide, inner salt], sodium salt
5-phenyl-2-[2-[[5-phenyl-3-(3-sulfopropyl)-2(3h)-benzoxazolylidene]methyl-1-butenyl]-3-(3-sulfopropyl)benzoxazolium hydroxide, inner salt], sodium salt
C37H35N2NaO8S2 (722.1732430000001)
2-[3-[1,1-Dimethyl-3-(4-sulfobutyl)-1,3-dihydro-benzo[e]indol-2-ylidene]-propenyl]-1,1-dimethyl-3-(4-sulfobutyl)-1H-benzo[e]indolium hydroxide, inner salt, sodium salt
2-[3-[1,1-Dimethyl-3-(4-sulfobutyl)-1,3-dihydro-benzo[e]indol-2-ylidene]-propenyl]-1,1-dimethyl-3-(4-sulfobutyl)-1H-benzo[e]indolium hydroxide, inner salt, sodium salt
C39H43N2NaO6S2 (722.2460098000001)
Obicetrapib
Obicetrapib (AMG-899,TA-8995)
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent
Brostallicin
Brostallicin
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
(+)-Jasplakinolide W
(+)-Jasplakinolide W
C36H43BrN4O7 (722.2314948000001)
A cyclodepsipeptide isolated from Jaspis splendens.
jaspamide B
jaspamide B
C36H43BrN4O7 (722.2314948000001)
A cyclodepsipeptide isolated from Jaspis splendens. A derivative of jaspamide, it exhibits anti-tumour activity.
5-[(1S,2R)-5,9-dihydroxy-2-(2-hydroxypropan-2-yl)-10-methoxy-11-methyl-6-oxo-1,2-dihydrofuro[2,3-c]acridin-1-yl]-6,10-dihydroxy-11-methoxy-3,3,12-trimethylpyrano[2,3-c]acridin-7-one
5-[(1S,2R)-5,9-dihydroxy-2-(2-hydroxypropan-2-yl)-10-methoxy-11-methyl-6-oxo-1,2-dihydrofuro[2,3-c]acridin-1-yl]-6,10-dihydroxy-11-methoxy-3,3,12-trimethylpyrano[2,3-c]acridin-7-one
C40H38N2O11 (722.2475478000001)
3,4,5-Trihydroxy-6-[1-methoxy-1,3-dioxo-3-[[3,4,5-trihydroxy-6-[5-hydroxy-3-(4-methoxyphenyl)-4-oxochromen-7-yl]oxyoxan-2-yl]methoxy]propan-2-yl]oxane-2-carboxylic acid
3,4,5-Trihydroxy-6-[1-methoxy-1,3-dioxo-3-[[3,4,5-trihydroxy-6-[5-hydroxy-3-(4-methoxyphenyl)-4-oxochromen-7-yl]oxyoxan-2-yl]methoxy]propan-2-yl]oxane-2-carboxylic acid
6-({8-[3,7-dihydroxy-2-(3-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-yl]-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-3,4-dihydro-2H-1-benzopyran-7-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
6-({8-[3,7-dihydroxy-2-(3-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-yl]-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-3,4-dihydro-2H-1-benzopyran-7-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
[(3S,5S,6S)-3,4,5-triacetyloxy-6-[(3R,4R,5S)-1,2,4,5,6-pentaacetyloxyhexan-3-yl]oxyoxan-2-yl]methyl acetate
[(3S,5S,6S)-3,4,5-triacetyloxy-6-[(3R,4R,5S)-1,2,4,5,6-pentaacetyloxyhexan-3-yl]oxyoxan-2-yl]methyl acetate
[(3S,5S,6S)-3,4,5-triacetyloxy-6-[(3R,4S,5R)-1,2,4,5,6-pentaacetyloxyhexan-3-yl]oxyoxan-2-yl]methyl acetate
[(3S,5S,6S)-3,4,5-triacetyloxy-6-[(3R,4S,5R)-1,2,4,5,6-pentaacetyloxyhexan-3-yl]oxyoxan-2-yl]methyl acetate
NGR peptide (Trifluoroacetate)
NGR peptide (Trifluoroacetate)
C22H37F3N10O10S2 (722.2087538000001)
NGR peptide Trifluoroacetatecontaining the Asn-Gly-Arg (NGR) motif. NGR peptide Trifluoroacetate binds to APN/CD13. NGR peptide Trifluoroacetate is directly conjugated to imaging agents that can be used for tumor imaging[1][2].
(2r,3r,4s,5s)-4,5-bis(acetyloxy)-2-{[(2r,3s,4s,5r,6s)-6-{[2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-4-oxochromen-5-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methoxy}oxan-3-yl acetate
(2r,3r,4s,5s)-4,5-bis(acetyloxy)-2-{[(2r,3s,4s,5r,6s)-6-{[2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-4-oxochromen-5-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methoxy}oxan-3-yl acetate
7-[(2-bromo-1h-indol-3-yl)methyl]-6,12-dihydroxy-4-(4-hydroxyphenyl)-8,10,13,17,19-pentamethyl-15-methylidene-1-oxa-5,8,11-triazacyclononadeca-5,11-diene-2,9,16-trione
7-[(2-bromo-1h-indol-3-yl)methyl]-6,12-dihydroxy-4-(4-hydroxyphenyl)-8,10,13,17,19-pentamethyl-15-methylidene-1-oxa-5,8,11-triazacyclononadeca-5,11-diene-2,9,16-trione
C36H43BrN4O7 (722.2314948000001)
[(2r,3s,4s,5r,6s)-5-(acetyloxy)-6-{[(2s,3r,4r,5s,6s)-3-(acetyloxy)-2-{2-[(2s)-5,7-dihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl]-4-hydroxyphenoxy}-5-hydroxy-6-methyloxan-4-yl]oxy}-3,4-dihydroxyoxan-2-yl]methyl acetate
[(2r,3s,4s,5r,6s)-5-(acetyloxy)-6-{[(2s,3r,4r,5s,6s)-3-(acetyloxy)-2-{2-[(2s)-5,7-dihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl]-4-hydroxyphenoxy}-5-hydroxy-6-methyloxan-4-yl]oxy}-3,4-dihydroxyoxan-2-yl]methyl acetate
(2s,3r,4r,5s,6s)-3,5-bis(acetyloxy)-2-{[(1s,2s,4s,5s,6s,10s)-2-(hydroxymethyl)-10-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl]oxy}-6-methyloxan-4-yl (2e)-3-phenylprop-2-enoate
(2s,3r,4r,5s,6s)-3,5-bis(acetyloxy)-2-{[(1s,2s,4s,5s,6s,10s)-2-(hydroxymethyl)-10-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl]oxy}-6-methyloxan-4-yl (2e)-3-phenylprop-2-enoate